Erwin F. Wagner

72.2k total citations · 19 hit papers
364 papers, 50.7k citations indexed

About

Erwin F. Wagner is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Erwin F. Wagner has authored 364 papers receiving a total of 50.7k indexed citations (citations by other indexed papers that have themselves been cited), including 242 papers in Molecular Biology, 133 papers in Oncology and 64 papers in Genetics. Recurrent topics in Erwin F. Wagner's work include Bone Metabolism and Diseases (53 papers), Cytokine Signaling Pathways and Interactions (46 papers) and NF-κB Signaling Pathways (35 papers). Erwin F. Wagner is often cited by papers focused on Bone Metabolism and Diseases (53 papers), Cytokine Signaling Pathways and Interactions (46 papers) and NF-κB Signaling Pathways (35 papers). Erwin F. Wagner collaborates with scholars based in Austria, Germany and Spain. Erwin F. Wagner's co-authors include Robert Eferl, Ángel R. Nebreda, Maria Sibilia, Gérard Karsenty, Zhao‐Qi Wang, Latifa Bakiri, Ulrich Rüther, Wolfram Jochum, Agamemnon E. Grigoriadis and Emmanuelle Passegué and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Erwin F. Wagner

359 papers receiving 49.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

2002 2.2k citations Erwin F. Wagner et al. profile →
Signal integration by JNK and p38 MAPK pathways in cancer development

2009 2.1k citations Erwin F. Wagner et al. profile →
AP-1: a double-edged sword in tumorigenesis

2003 1.8k citations Robert Eferl, Erwin F. Wagner profile →
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells

1988 1.5k citations Erwin F. Wagner et al. profile →
Evidence for osteocyte regulation of bone homeostasis through RANKL expression

2011 1.3k citations Erwin F. Wagner et al. profile →
Reaching a Genetic and Molecular Understanding of Skeletal Development

2002 1.2k citations Erwin F. Wagner et al. profile →
Defective Lipolysis and Altered Energy Metabolism in Mice Lacking Adipose Triglyceride Lipase

2006 1.1k citations Erwin F. Wagner et al. profile →
c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling

1994 1.0k citations Erwin F. Wagner et al. profile →
Strain-Dependent Epithelial Defects in Mice Lacking the EGF Receptor

1995 824 citations Maria Sibilia, Erwin F. Wagner profile →
Bone and haematopoietic defects in mice lacking c-fos

1992 768 citations Uta Möhle-Steinlein, Erwin F. Wagner et al. profile →
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

2005 731 citations Erwin F. Wagner et al. profile →
Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

1995 673 citations Erwin F. Wagner et al. profile →
Distinct Neural Stem Cells Proliferate in Response to EGF and FGF in the Developing Mouse Telencephalon

1999 661 citations Maria Sibilia, Erwin F. Wagner et al. profile →
AP-1 in mouse development and tumorigenesis

2001 608 citations Erwin F. Wagner et al. profile →
Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation

1999 591 citations Maria Sibilia, Erwin F. Wagner et al. profile →
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

2002 574 citations Erwin F. Wagner et al. profile →
A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia

2014 555 citations Michele Petruzzelli, Erwin F. Wagner et al. profile →
Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors

1985 494 citations Erwin F. Wagner et al. profile →
Calprotectin: from biomarker to biological function

2021 274 citations Latifa Bakiri, Erwin F. Wagner et al. profile →

Peers

Countries citing papers authored by Erwin F. Wagner

Since Specialization

Citations

This map shows the geographic impact of Erwin F. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin F. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin F. Wagner more than expected).

Fields of papers citing papers by Erwin F. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin F. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin F. Wagner. The network helps show where Erwin F. Wagner may publish in the future.

Co-authorship network of co-authors of Erwin F. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Erwin F. Wagner. A scholar is included among the top collaborators of Erwin F. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin F. Wagner. Erwin F. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fatty acid-binding protein 5 aggravates psoriasis and psoriasis-like disease through ferroptosis 2025 ·Cell Death and Differentiation ·(unknown), Latifa Bakiri, (unknown), Kazuhiko Matsuoka, Erwin F. Wagner	0
2	Chronic skin and systemic inflammation modulated by S100A8 and S100A9 complexes 4737 2025 ·The Journal of Immunology ·Marta Palomo-Irigoyen, Latifa Bakiri, Tim Hendrikx, Silvia Hayer, Johanna Schaffenrath, Stefanie Widder, (unknown), (unknown), Richard L. Gallo, Philipp Starkl, Johannes Roth, Erwin F. Wagner	0
3	A new effLuc/Kate dual reporter allele for tumor imaging in mice 2025 ·Disease Models & Mechanisms ·Latifa Bakiri, Mélanie Tichet, Carolina Marques, Martin K. Thomsen, (unknown), (unknown), (unknown), Kazuhiko Matsuoka, Massimo Squatrito, Douglas Hanahan, Erwin F. Wagner	0
4	Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity 2024 ·Blood Cancer Journal ·Judith Lind, (unknown), Michaela Prchal‐Murphy, Fengjuan Fan, Mariateresa Fulciniti, Dagmar Stoiber, Latifa Bakiri, Erwin F. Wagner, (unknown), Martin Sattler, Karoline Kollmann, Sonia Vallet, Klaus Podar	3
5	Early Neutrophilia Marked by Aerobic Glycolysis Sustains Host Metabolism and Delays Cancer Cachexia 2022 ·Cancers ·Michele Petruzzelli, Miriam Ferrer, Martijn J. Schuijs, Sam O. Kleeman, (unknown), Zoe Hall, David Perera, (unknown), Michèle Vacca, Edoardo Gaude, Michael J. Lukey, Duncan I. Jodrell, Christian Frezza, Erwin F. Wagner, Ashok R. Venkitaraman, Timotheus Y.F. Halim, Tobias Janowitz	15
6	Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease 2022 ·Annals of the Rheumatic Diseases ·Liliana F. Mellor, Nuria Gago‐López, Latifa Bakiri, Felix N. Schmidt, Björn Busse, Simon Rauber, María Jiménez, Diego Megı́as, (unknown), Ricardo Sánchez‐Prieto, Sergei I. Grivennikov, Xinzhu Pu, Julia Thom Oxford, Andreas Ramming, Georg Schett, Erwin F. Wagner	34
7	Syndecan-1 shedding by meprin β impairs keratinocyte adhesion and differentiation in hyperkeratosis 2021 ·Matrix Biology ·Florian Peters, Sascha Rahn, (unknown), Franka Scharfenberg, Anna Otte, Tomas Koudelka, Erwin F. Wagner, F. Thomas Wunderlich, Michael Haase, Ronald Naumann, Andreas Tholey, Christoph Becker‐Pauly	9
8	Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction 2015 ·Nature Cell Biology ·Craig S. Nowell, Pascal D. Odermatt, Luca Azzolin, (unknown), Erwin F. Wagner, Georg E. Fantner, Matthias P. Lütolf, Yann Barrandon, Stefano Piccolo, Freddy Radtke	119
9	Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis 2009 ·Proceedings of the National Academy of Sciences ·Helia B. Schönthaler, Reto Huggenberger, Stefanie K. Wculek, Michael Detmar, Erwin F. Wagner	124
10	Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling 2009 ·Proceedings of the National Academy of Sciences ·(unknown), Paul Vesely, Brigitte Hantusch, Michaela Schlederer, Rainer Zenz, (unknown), G Steiner, Arabella Meixner, Peter Petzelbauer, Peter Wolf, Afschin Soleiman, Gerda Egger, Richard Moriggl, Tadamitsu Kishimoto, Erwin F. Wagner, Lukas Kenner	57
11	Podoplanin Is a Novel Fos Target Gene in Skin Carcinogenesis 2008 ·Cancer Research ·Moritz Durchdewald, Juan Guinea‐Viniegra, Daniel Haag, Astrid Riehl, Peter Lichter, Meinhard Hahn, Erwin F. Wagner, Peter Angel, Jochen Heß	56
12	EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer 2008 ·Nature Cell Biology ·Vihren N. Kolev, Anna Mandinova, Juan Guinea‐Viniegra, Bing Hu, Karine Lefort, Chiara Lambertini, Victor Neel, Reinhard Dummer, Erwin F. Wagner, G. Paolo Dotto	159
13	Essential role of RSK2 in c-Fos–dependent osteosarcoma development 2005 ·Journal of Clinical Investigation ·Jean‐Pierre David, (unknown), Latifa Bakiri, Arndt F. Schilling, Vice Mandic, Matthias Priemel, (unknown), Markus Reschke, Oskar Hoffmann, Michael Amling, Erwin F. Wagner	80
14	Loss of Fra-2 expression leads to osteoporosis 2003 ·Calcified Tissue International ·Astrid Hoebertz, Robert Eferl, Florian A. Karreth, A. Schilling, (unknown), (unknown), Erwin F. Wagner	1
15	Osteoclasts are essential for TNF-α–mediated joint destruction 2002 ·Journal of Clinical Investigation ·Kurt Redlich, Silvia Hayer, Roméo Ricci, Jean‐Pierre David, M Tohidast-Akrad, George Kollias, G Steiner, Josef S Smolen, Erwin F. Wagner, Georg Schett	29
16	Osteoclasts are essential for TNF-α–mediated joint destruction 2002 ·Journal of Clinical Investigation ·Kurt Redlich, Silvia Hayer, Roméo Ricci, Jean‐Pierre David, M Tohidast-Akrad, George Kollias, G Steiner, Josef S Smolen, Erwin F. Wagner, Georg Schett	400
17	Differential Utilization and Localization of ErbB Receptor Tyrosine Kinases in Skin Compared to Normal and Malignant Keratinocytes 2001 ·Neoplasia ·Stefan Stoll, Sanjay Kansra, (unknown), David W. Fry, Wilbur R. Leopold, Jane F. Wiesen, Maria Sibilia, Tong Zhang, Zena Werb, Rik Derynck, Erwin F. Wagner, James T. Elder	65
18	Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. 1995 ·PubMed ·Sabine Brüsselbach, Uta Möhle-Steinlein, Zhiqin Wang, Martin Schreiber, Frances C. Lucibello, Rolf Müller, Erwin F. Wagner	51
19	Localization of regulatory elements controlling human MYCN expression. 1991 ·PubMed ·Sebastian Hiller, Stephen Breit, (unknown), Erwin F. Wagner, M. Schwab	30
20	Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. 1990 ·PubMed ·Adriano Aguzzi, Erwin F. Wagner, (unknown), Sara A. Courtneidge	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact